AlphaHelix has developed a system for screening bacteria, based on molecular diagnostics. The BugScreener™ system has outstanding performance in time, cost and sensitivity. It can be used for MRSA, VRE and other hazardous bacteria. The BugScreener™ has over nine years of proven concept in numerous major diagnostics’ laboratories. Over 2 million samples have been successfully processed by the system.
The backbone of the BugScreener™ is a DNA extraction process. After cultivation, the samples are processed through a unique extraction process; enabling regular qPCR (quantitative polymerase chain reaction) analysis. The lead time from sampling to result is well under 24 hours.
The module philosophy of The BugScreener™ enables laboratories to choose their optimal solution; based on sample quantity. The System can be used with manual pipetting as well as large robotic setups with barcode solutions; customized for The BugScreener™ by AlphaHelix. The BugScreener™ can handle up to 200.000 samples per year in one robotics line. The qPCR functionality and mix are optional modules in the system.
Cost-efficiency is an important factor in any large quantity analysis. The BugScreener™ provides a full screening solution at a cost far lower than any other system in the market. AlphaHelix offers a full “pay-per-sample”-solution; including optimal robotics and service; which will eliminate initial investment costs. The user can feel safe to always have a safe and functional solution running. In addition will a full “pay-per-sample” solution always ensures optimal function and process capacity of The BugScreenerTM.
The speed of the system enables hospitals to limit isolation time of suspected MRSA patients, saving money when reducing allocated care time. This increased benefit for the hospitals and their patients enables laboratories to sell The BugScreener™ services at higher cost than regular screening; despite the actual lower cost.